ELOTUZUMAB - INJECTION

ELOTUZUMAB - INJECTION

PHONETIC PRONUNCIATION: (EL-oh-TOOZ-ue-mab)

COMMON BRAND NAME(S): Empliciti

GENERIC NAME(S): elotuzumab

Uses

USES: Elotuzumab is used along with other medications (lenalidomide, dexamethasone) to treat a certain type of cancer (multiple myeloma).


How to use ELOTUZUMAB - INJECTION

HOW TO USE: Read the Patient Information Leaflet if available from your pharmacist before you start using elotuzumab and each time you receive the medication. If you have any questions, ask your doctor or pharmacist. This medication is given by injection into a vein by a health care professional. It is given as directed by your doctor, usually once a week for the first 8 weeks. After that it is usually given once every 2 weeks. The dosage is based on your weight. To help prevent side effects (infusion reactions), your doctor may direct you to use other medications before you receive this medication. Use these additional medications exactly as directed by your doctor. Tell your doctor right away if you have any symptoms of infusion reactions such as fever, chills, dizziness, and slow heartbeat.

Side Effects

SIDE EFFECTS: See also How to Use section. Loss of appetite, weight loss, diarrhea, constipation, headache, or tiredness may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly. Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Tell your doctor right away if you have any serious side effects, including: signs of liver disease (such as nausea/vomiting that doesn't stop, loss of appetite, stomach/abdominal pain, yellowing eyes/skin, dark urine), numbness/tingling of arms/legs, easy bruising/bleeding, fainting, fast/irregular heartbeat, mental/mood changes, muscle spasms/weakness, unusual tiredness, increased thirst/urination. This medication may lower your ability to fight infections. This may make you more likely to get a serious (rarely fatal) infection or make any infection you have worse. Tell your doctor right away if you have any signs of infection (such as sore throat that doesn't go away, fever, chills, cough). People who are treated with this medication may rarely get other cancers (such as skin cancer). Consult your doctor for more details. A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

Precautions

PRECAUTIONS: Before using elotuzumab, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. Before using this medication, tell your doctor or pharmacist your medical history, especially of: liver disease, current/recent infection. Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). Elotuzumab can make you more likely to get infections or may worsen any current infections. Avoid contact with people who have infections that may spread to others (such as chickenpox, measles, flu). Consult your doctor if you have been exposed to an infection or for more details. Do not have immunizations/vaccinations without the consent of your doctor. Avoid contact with people who have recently received live vaccines (such as flu vaccine inhaled through the nose). To lower the chance of getting cut, bruised, or injured, use caution with sharp objects like razors and nail cutters, and avoid activities such as contact sports. Elotuzumab, when used in combination with lenalidomide, must not be used during pregnancy. The combination may cause harm (possibly death) to an unborn baby. Two reliable forms of birth control (such as condoms, birth control pills) must be used whenever at least one sexual partner is using these medicines together. Males using these medications must always use a condom during sexual activity. If you or your partner become pregnant, or if you think you or your partner may be pregnant, tell your doctor right away. It is unknown if this drug passes into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug and lenalidomide is not recommended. Consult your doctor before breast-feeding.

Interactions

DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval.

Overdose

OVERDOSE: If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.

Images


color
colorless
shape
imprint

color
colorless
shape
imprint

Reviews

No Reviews Yet


Faq for ELOTUZUMAB - INJECTION

Elotuzumab injection is used to treat multiple myeloma, a type of cancer that affects plasma cells in the bone marrow.

Elotuzumab works by targeting a specific protein called SLAMF7, which is found on multiple myeloma cells. By binding to SLAMF7, elotuzumab activates the body's immune system to attack and kill the cancer cells.

Elotuzumab injection is given directly into a vein (intravenous infusion) by a healthcare professional.

Common side effects of elotuzumab injection include fatigue, fever, cough, diarrhea, constipation, nausea, infections, and rash. It is important to discuss any side effects with your healthcare provider.

Elotuzumab injection should not be used by individuals with a known allergy to elotuzumab or any of the components of the medication. It is important to inform your healthcare provider about any allergies or medical conditions you have before starting treatment.

The duration of elotuzumab treatment can vary depending on individual response and treatment plan. It may be prescribed as part of a combination therapy, and the treatment duration will be determined by your healthcare provider.

Elotuzumab injection is not a cure for multiple myeloma but is used as a part of a treatment plan to help control the disease and improve overall survival. It is important to continue follow-up appointments and treatments as recommended by your healthcare provider.

Elotuzumab injection may interact with certain medications, including immunosuppressants and live vaccines. It is important to inform your healthcare provider about all medications and vaccines you are taking before starting treatment with elotuzumab.

The dosing frequency of elotuzumab injection can vary depending on the treatment plan prescribed by your healthcare provider. Typically, elotuzumab is given once a week for the first two cycles and then every two weeks thereafter.



Disclaimer

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.